Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
November 18 2020 - 8:26AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November, 2020
Commission File Number: 001-37891
AC IMMUNE SA
(Exact name of registrant as specified
in its charter)
EPFL Innovation Park
Building B
1015 Lausanne, Switzerland
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
AC IMMUNE SA
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Andrea Pfeifer
|
|
|
|
|
|
Name:
|
Andrea Pfeifer
|
|
|
|
|
|
Title:
|
Chief Executive Officer
|
|
|
|
|
By:
|
/s/ Joerg Hornstein
|
|
|
|
|
|
Name:
|
Joerg Hornstein
|
|
|
|
|
|
Title:
|
Chief Financial Officer
|
|
Date: November 18, 2020
EXHIBIT INDEX
|
Exhibit
Number
|
Description
|
|
99.1
|
Press Release dated November 18, 2020
|
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Mar 2024 to Apr 2024
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Apr 2023 to Apr 2024
